Inventor
RILEY JAMES L
US24 patents
⚠️ This page may combine multiple inventors who share the name “RILEY JAMES L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV PENNSYLVANIA
15 patentsUS7754482B2Jul 13, 2010
Artificial antigen presenting cells and uses therefor
UNIV PENNSYLVANIA109 citations96
US9555105B2Jan 31, 2017
Artificial antigen presenting cells and uses thereof
UNIV PENNSYLVANIA18 citations90
US7651855B2Jan 26, 2010
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses
UNIV PENNSYLVANIA11 citations82
US9994818B2Jun 12, 2018
ICOS critically regulates the expansion and function of inflammatory human Th17 cells
UNIV PENNSYLVANIA2 citations71
US10286066B2May 14, 2019
Artificial antigen presenting cells and uses thereof
UNIV PENNSYLVANIA3 citations70
US10738099B2Aug 11, 2020
Method of redirecting T cells to treat HIV infection
UNIV PENNSYLVANIA2 citations69
US10808225B2Oct 20, 2020
Use of PDL1 expressing cells to convert T cells into regulatory T cells
UNIV PENNSYLVANIA2 citations68
US9644179B2May 9, 2017
Use of PDL1 expressing cells to convert T cells into regulatory T cells
UNIV PENNSYLVANIA4 citations68
US11001805B2May 11, 2021
ICOS critically regulates the expansion and function of inflammatory human Th17 cells
UNIV PENNSYLVANIA0 citations61
US10874727B2Dec 29, 2020
Inducible regulatory t-cell generation for hematopoietic transplants
UNIV PENNSYLVANIA1 citations60
US12122820B2Oct 22, 2024
Method of redirecting t cells to treat HIV infection
UNIV PENNSYLVANIA0 citations59
US9453199B2Sep 27, 2016
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
UNIV PENNSYLVANIA1 citations58
US11827705B2Nov 28, 2023
Methods to protect transplanted tissue from rejection
UNIV PENNSYLVANIA1 citations55
US12497623B2Dec 16, 2025
Non-signaling HIV fusion inhibitors and methods of use thereof
UNIV PENNSYLVANIA0 citations52
US9255279B2Feb 9, 2016
Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cells
UNIV PENNSYLVANIA0 citations49
RILEY JAMES L
3 patentsUS8722400B2May 13, 2014
Artificial antigen presenting cells and uses therefor
RILEY JAMES L87 citations95
US9133436B2Sep 15, 2015
ICOS critically regulates the expansion and function of inflammatory human Th17 cells
RILEY JAMES L16 citations89
US9228172B2Jan 5, 2016
Inducible regulatory T-cell generation for hematopoietic transplants
RILEY JAMES L2 citations60